SRS284 - Serious adverse events and early readmissions following total shoulder arthroplasty: a systematic review
British Journal of Surgery · 27.03.2026 · 113 (Supplement_2)
DOI: 10.1093/bjs/znag018.260 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift British Journal of Surgery, online erschienen am 27.03.2026. Verfasst von Hussayn Shinwari und 7 weiteren Autor:innen.
Themen: Patientensicherheit
Abstract (Originalsprache)
Background
Total shoulder arthroplasty (TSA) is increasingly performed for degenerative and traumatic shoulder conditions. Although outcomes are generally favourable, serious adverse events (SAEs) and early hospital readmissions remain a clinical concern. This systematic review quantifies SAE incidence, 30- and 90-day readmissions, and identifies key risk factors.
Methods
Systematic searches of major databases identified 1437 records. After screening and eligibility assessment, 301 studies were included, encompassing >2 million TSA patients. Studies reporting SAEs or early readmissions in relation to demographic, clinical, or procedural variables were eligible.
Results
Overall SAE incidence ranged 0.1–13.6%, including medical complications (anemia 0.1–13.6%, pneumonia 0.2–2.6%, sepsis 0.4–1.4%, PE 0.2–1.6%, DVT 0.3–1.3%, MI 0.2–0.4%, AKI 0.4–3.9%) and surgical complications (periprosthetic fracture 0.3–0.5%, dislocation 0.1–1.3%, infection 0.3–1.5%, device failure 0.03–0.36%). Thirty-day readmission rates were 1.8–7.8%, and 90-day 2.1–9.7%, with infection, anemia, cardiovascular events, and surgical complications as leading causes. Risk factors consistently identified included age >85, ASA ≥3, dependent functional status, CHF, bleeding disorders, non-home discharge, and disseminated cancer. Perioperative IV dexamethasone reduced sepsis (RR 0.45), AKI (RR 0.64), UTI (RR 0.55), and 90-day readmission (RR 0.61) in large cohort studies. Subgroup analyses highlighted higher SAE rates in reverse TSA compared with anatomic TSA, and in patients with multiple comorbidities.
Conclusions
SAEs and early readmissions following TSA are uncommon but clinically significant. Optimisation of comorbidities, functional status, discharge planning, and perioperative care can mitigate risk, improving outcomes in this growing patient population.
Zitieren
APA
Shinwari, H., Tahir, U., Popal, A., Shinwari, H., Vural, D., Kamath, A., Gill, S., & Sugand, K. (2026). SRS284 - Serious adverse events and early readmissions following total shoulder arthroplasty: a systematic review. British Journal of Surgery, 113(Supplement_2). https://doi.org/10.1093/bjs/znag018.260
Vancouver
Shinwari H, Tahir U, Popal A, Shinwari H, Vural D, Kamath A, et al. SRS284 - Serious adverse events and early readmissions following total shoulder arthroplasty: a systematic review. British Journal of Surgery. 2026;113(Supplement_2). doi:10.1093/bjs/znag018.260
BibTeX
@article{Shinwari2026,
author = {Shinwari, Hussayn and Tahir, Usman and Popal, Ahmed and Shinwari, Hanan and Vural, Deniz and Kamath, Abith and Gill, Saran and Sugand, Kapil},
title = {SRS284 - Serious adverse events and early readmissions following total shoulder arthroplasty: a systematic review},
journal = {British Journal of Surgery},
year = {2026},
volume = {113},
number = {Supplement_2},
doi = {10.1093/bjs/znag018.260}
}
EUVIMED